Skip to main content

Drugmaker Vertex to delay new clinical studies due to coronavirus

U.S. drugmaker Vertex Pharmaceuticals Inc said on Friday it would delay starting some clinical trials and temporarily pause enrolment in some studies, as it looks to free up hospitals to deal with the coronavirus outbreak.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.